UBS lowered the firm’s price target on Lear to $136 from $142 and keeps a Neutral rating on the shares. While UBS is encouraged by some potential mid-term developments, growth is likely to be choppy over the next 12-18 months, which could limit margin expansion, the analyst tells investors in a research note. The firm sees 15% downside risk to 2025 consensus estimates but believes the market is pricing in levels closer to the new forecast.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEA: